Terry J. Smith

Graves’ Disease

Teprotumumab for Thyroid-Associated Ophthalmopathy

Teprotumumab for the Treatment of Active Thyroid Eye Disease

MRI characteristics of neuromyelitis optica spectrum disorder

Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease

ICRP Publication 137: Occupational Intakes of Radionuclides: Part 3

Connective Tissue, Glycosaminoglycans, and Diseases the Thyroid*

Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway

Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes